BCAS3 anticorps (C-Term)
Aperçu rapide pour BCAS3 anticorps (C-Term) (ABIN356926)
Antigène
Voir toutes BCAS3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibodfy detects BCAS3 at C-term.
-
Purification
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
-
Immunogène
- KLH conjugated synthetic peptide selected from the C-terminal region of human BCAS3
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
-
ELISA 1: 1,000. Western blot 1: 50 - 1: 100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- BCAS3 (Breast Carcinoma Amplified Sequence 3 (BCAS3))
-
Autre désignation
- BCAS3 / GAOB1
-
Sujet
- BCAS3 is physically associated with histone H3 and histone acetyltransferase complex protein P/CAF (p300/CBP-associated factor) and possesses histone acetyltransferase activity. In breast cancer, several chromosomal sites frequently undergo amplification, implicating the location of genes important for tumor development and progression.Synonyms: Breast carcinoma-amplified sequence 3, Maab1 protein
-
Poids moléculaire
- 101181 Da
-
ID gène
- 54828, 9606
-
UniProt
- Q9H6U6
Antigène
-